Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309367882> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4309367882 endingPage "22" @default.
- W4309367882 startingPage "15" @default.
- W4309367882 abstract "Assessment of COVID-19 incidence and hospitalization rate of male patients with prostatic hyperplasia depending on the intake of 5-alpha-reductase inhibitors (5-ARI).In our study, electronic medical records of 1678 patients with prostatic hyperplasia were analyzed. 1490 men aged 71 (64-76) years were selected for final analysis. Vaccination against COVID-19 was carried out in 730 patients (49%). Treatment with 5-ARI inhibitors was carried out in 269 (18.1%) patients.Among 1490 included patients 790 (53%) had COVID- 19 while 360 (45.7%) of them required hospitalization. During the multivariate analysis, only two factors were associated with the risk of COVID-19 in the cohort studied: vaccination (odds ratio (OR) =0.095; 95% confidence interval (CI) 0.074-0.122), i.e. a 90.5% chance reduction, p<0.001) and the fact of taking 5-ARI (OR=0.235; 95%CI=0.165-0.335; p<0.001), i.e. a 76.5% chance reduction. The duration of 5-ARI therapy was not associated with the incidence of new coronavirus infection. The severe course of COVID-19 which required hospitalization was positively associated with age (p=0.025) and the presence of coronary artery disease (p=0.004); and negatively associated with the frequency of vaccination (p<0.001) and treatment of 5-ARI (3.1% vs. 11.6%, p<0.001). In a multivariate analysis of outpatient patients with prostatic hyperplasia who had COVID-19, 5-ARI intake (OR=0.240; 95% CI 0.122-0.473; p<0.001) and vaccination (OR = 0.570; 95% CI 0.401-0.808; p=0.002). The factors associated with increased chances of hospitalization due to the severe course of COVID-19 were coronary heart disease (+43.8%, p=0.019) and older age (+1.7% by one year, p=0.046).Taking 5-ARI, along with vaccination in patients with prostatic hyperplasia is a protective factor for morbidity and the severity of COVID-19." @default.
- W4309367882 created "2022-11-26" @default.
- W4309367882 creator A5001292864 @default.
- W4309367882 creator A5001716517 @default.
- W4309367882 creator A5004639592 @default.
- W4309367882 creator A5010481003 @default.
- W4309367882 creator A5023893781 @default.
- W4309367882 creator A5034221512 @default.
- W4309367882 creator A5039602124 @default.
- W4309367882 creator A5063065981 @default.
- W4309367882 creator A5070243346 @default.
- W4309367882 creator A5072176403 @default.
- W4309367882 creator A5085264591 @default.
- W4309367882 date "2022-11-01" @default.
- W4309367882 modified "2023-09-29" @default.
- W4309367882 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36382812" @default.
- W4309367882 hasPublicationYear "2022" @default.
- W4309367882 type Work @default.
- W4309367882 citedByCount "0" @default.
- W4309367882 crossrefType "journal-article" @default.
- W4309367882 hasAuthorship W4309367882A5001292864 @default.
- W4309367882 hasAuthorship W4309367882A5001716517 @default.
- W4309367882 hasAuthorship W4309367882A5004639592 @default.
- W4309367882 hasAuthorship W4309367882A5010481003 @default.
- W4309367882 hasAuthorship W4309367882A5023893781 @default.
- W4309367882 hasAuthorship W4309367882A5034221512 @default.
- W4309367882 hasAuthorship W4309367882A5039602124 @default.
- W4309367882 hasAuthorship W4309367882A5063065981 @default.
- W4309367882 hasAuthorship W4309367882A5070243346 @default.
- W4309367882 hasAuthorship W4309367882A5072176403 @default.
- W4309367882 hasAuthorship W4309367882A5085264591 @default.
- W4309367882 hasConcept C120665830 @default.
- W4309367882 hasConcept C121332964 @default.
- W4309367882 hasConcept C126322002 @default.
- W4309367882 hasConcept C156957248 @default.
- W4309367882 hasConcept C203014093 @default.
- W4309367882 hasConcept C22070199 @default.
- W4309367882 hasConcept C2777562237 @default.
- W4309367882 hasConcept C2779134260 @default.
- W4309367882 hasConcept C3008058167 @default.
- W4309367882 hasConcept C38180746 @default.
- W4309367882 hasConcept C44249647 @default.
- W4309367882 hasConcept C524204448 @default.
- W4309367882 hasConcept C61511704 @default.
- W4309367882 hasConcept C71924100 @default.
- W4309367882 hasConcept C90924648 @default.
- W4309367882 hasConceptScore W4309367882C120665830 @default.
- W4309367882 hasConceptScore W4309367882C121332964 @default.
- W4309367882 hasConceptScore W4309367882C126322002 @default.
- W4309367882 hasConceptScore W4309367882C156957248 @default.
- W4309367882 hasConceptScore W4309367882C203014093 @default.
- W4309367882 hasConceptScore W4309367882C22070199 @default.
- W4309367882 hasConceptScore W4309367882C2777562237 @default.
- W4309367882 hasConceptScore W4309367882C2779134260 @default.
- W4309367882 hasConceptScore W4309367882C3008058167 @default.
- W4309367882 hasConceptScore W4309367882C38180746 @default.
- W4309367882 hasConceptScore W4309367882C44249647 @default.
- W4309367882 hasConceptScore W4309367882C524204448 @default.
- W4309367882 hasConceptScore W4309367882C61511704 @default.
- W4309367882 hasConceptScore W4309367882C71924100 @default.
- W4309367882 hasConceptScore W4309367882C90924648 @default.
- W4309367882 hasIssue "5" @default.
- W4309367882 hasLocation W43093678821 @default.
- W4309367882 hasOpenAccess W4309367882 @default.
- W4309367882 hasPrimaryLocation W43093678821 @default.
- W4309367882 hasRelatedWork W1967309655 @default.
- W4309367882 hasRelatedWork W2325084897 @default.
- W4309367882 hasRelatedWork W2339604458 @default.
- W4309367882 hasRelatedWork W2608661137 @default.
- W4309367882 hasRelatedWork W2909450172 @default.
- W4309367882 hasRelatedWork W2962230309 @default.
- W4309367882 hasRelatedWork W3213017456 @default.
- W4309367882 hasRelatedWork W4205897696 @default.
- W4309367882 hasRelatedWork W4280624396 @default.
- W4309367882 hasRelatedWork W4281257635 @default.
- W4309367882 isParatext "false" @default.
- W4309367882 isRetracted "false" @default.
- W4309367882 workType "article" @default.